• 1
    El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340:745750.
  • 2
    Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334:16851690.
  • 3
    Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, et al. The risk of transmission of hepatitis B from HBsAg(−), HBcAb(+), HBIgM(−) organ donors. Transplantation 1995; 59:230234.
  • 4
    Schories M, Peters T, Rasenack J. Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. J Hepatol 2000; 33:799811.
  • 5
    Blackberg J, Kidd-Ljunggren K. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 2000; 33:992997.
  • 6
    Blum HE, Liang TJ, Galun E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991; 14:5663.
  • 7
    Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”? Hepatology 2001; 34:194203.
  • 8
    Chazouilleres O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, et al. “Occult” hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343:142146.
  • 9
    Fong TL, Dibisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of hepatitis-B virus DNA in the liver after loss of HBsAg in chronic hepatitis-B. Hepatology 1993; 18:13131318.
  • 10
    Grethe S, Monazahian M, Bohme I, Thomssen R. Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol 1998; 72:76927696.
  • 11
    Kremsdorf D, Garreau F, Duclos H, Thiers V, Schellekens H, Petit MA, Brechot C. Complete nucleotide sequence and viral envelope protein expression of a hepatitis-B virus DNA derived from a hepatitis-B surface antigen-seronegative patient. J Hepatol 1993; 18:244250.
  • 12
    Loriot MA, Marcellin P, Walker F, Boyer N, Degott C, Randrianatoavina I, Benhamou JP, et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 1997; 27:251258.
  • 13
    Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, Tsutsumi A, et al. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. J Med Virol 2000; 62:151158.
  • 14
    Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, Goudeau A, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988; 2:12731276.
  • 15
    Baginski I, Chemin I, Hantz O, Pichoud C, Jullien AM, Chevre JC, Li JS, et al. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis. Transfusion 1992; 32:215220.
  • 16
    Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341:2226.
  • 17
    Uchida T, Kaneita Y, Gotoh K, Kanagawa H, Kouyama H, Kawanishi T, Mima S. Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection. J Med Virol 1997; 52:399405.
  • 18
    Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998; 17:613.
  • 19
    Jilg W, Sieger E, Zachoval R, Schatzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995; 23:1420.
  • 20
    Sanchez-Quijano A, Jauregui JI, Leal M, Pineda JA, Castilla A, Abad MA, Civeira MP, et al. Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol 1993; 17:288293.
  • 21
    Chen WN, Oon CJ, Toh I. Altered antigenicities of hepatitis B virus surface antigen carrying mutations outside the common “a” determinant. Am J Gastroenterol 2000; 95:10981099.
  • 22
    Ireland JH, O'Donnell B, Basuni AA, Kean JD, Wallace LA, Lau GK, Carman WF. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 2000; 31:11761182.
  • 23
    Weinberger KM, Bauer T, Bohm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000; 81:11651174.
  • 24
    Weinberger KM, Zoulek G, Bauer T, Bohm S, Jilg W. A novel deletion mutant of hepatitis B virus surface antigen. J Med Virol 1999; 58:105110.
  • 25
    Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, Cova L, et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol 2001; 34:447454.
  • 26
    Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995; 69:54375444.
  • 27
    Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979; 280:646650.
  • 28
    Mabit H, Dubanchet S, Capel F, Dauguet C, Petit MA. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences. J Gen Virol 1994; 75:26812689.
  • 29
    Persson B, Argos P. Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J Mol Biol 1994; 237:182192.
  • 30
    Oon CJ, Chen WN, Koh S, Lim GK. Identification of hepatitis B surface antigen variants with alterations outside the “a” determinant in immunized Singapore infants. J Infect Dis 1999; 179:259263.
  • 31
    Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa Y, Mayuli M. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adry or adwy. J Virol 1987; 61:30303034.
  • 32
    Li J, Buckwold VE, Hon MW, Ou JH. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J Virol 1999; 73:12391244.
  • 33
    Yamanaka T, Akahane Y, Suzuki H, Okamoto H, Tsuda F, Miyakawa Y, Mayumi M. Hepatitis B surface antigen particles with all four subtypic determinants: point mutations of hepatitis B virus DNA inducing phenotypic changes or double infection with viruses of different subtypes. Mol Immunol 1990; 27:443449.
  • 34
    Raney AK, McLachlan A. Characterization of the hepatitis B virus major surface antigen promoter hepatocyte nuclear factor 3 binding site. J Gen Virol 1997; 78:30293038.
  • 35
    Shaul Y, Ben-Levy R, De-Medina T. High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter. EMBO J 1986; 5:19671971.
  • 36
    Lu CC, Yen TSB. Activation of the hepatitis B virus S promoter by transcription factor NF-Y via a CCAAT element. Virology 1996; 225:387394.
  • 37
    Raney AK, Le HB, McLachlan A. Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor. J Virol 1992; 66:69126921.
  • 38
    Zhou DX, Yen TS. Differential regulation of the hepatitis B virus surface gene promoters by a second viral enhancer. J Biol Chem 1990; 265:2073120734.
  • 39
    Bruss V, Gerhardt E, Vieluf K, Wunderlich G. Functions of the large hepatitis B virus surface protein in viral particle morphogenesis. Intervirology 1996; 39:2331.
  • 40
    Standring DN, Ou JH, Rutter WJ. Assembly of viral particles in Xenopus oocytes: pre-surface antigens regulate secretion of the hepatitis B viral surface envelope particle. Proc Nat Acad Sci U S A 1986; 83:93389342.
  • 41
    Lu CC, Chen M, Ou JH, Yen TSB. Key role of a CCAAT element in regulating hepatitis B virus surface protein expression. Virology 1995; 206:11551158.
  • 42
    Bock CT, Tillmann HL, Manns MP, Trautwein C. The pre-S region determines the intracellular localization and appearance of hepatitis B virus. Hepatology 1999; 30:517525.
  • 43
    Bock CT, Kubicka S, Manns MP, Trautwein C. Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor. Hepatology 1999; 29:12361247.